Pennsylvania-based Geneos Therapeutics is using its clinically validated GT-EPIC platform to generate cancer immunotherapies with high neoantigen payloads, and more. Despite the promise of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback